Rauwolfia Tablets ,Primidone Tablets ,Trepibutone Tablets Medicine,Health Food Co., Ltd. , http://www.cn-medicines.com
(17α,20E)-17,20-[(1-methoxyethylidene)bis-(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester (YK11), which the myogenic differentiation of C2C12 myoblast cells is induced by the novel androgen receptor (AR) partial agonist.Â
YK11 is a selective androgen receptor modulator (SARM), which activates AR without the N/C interaction. In this study, we further investigated the mechanism by which YK11 induces myogenic differentiation of C2C12 cells. The induction of key myogenic regulatory factors (MRFs), such as myogenic differentiation factor (MyoD), myogenic factor 5 (Myf5) and myogenin, was more significant in the presence of YK11 than in the presence of DHT. YK11 treatment of C2C12 cells, but not DHT, induced the expression of follistatin (Fst), and the YK11-mediated myogenic differentiation was reversed by anti-Fst antibody.
Myogenic differentiation is in reference to the products ability to block myostatin. Myostatin inhibition has been a really popular movement since the ban of most prohormones as it looks to be a relatively unexplored area for muscle growth and fat loss. There are currently a lot of claims about mystatin inhibition, but not so much factual data on these products. YK11 will have similar affects to DHT (possibly more potent) without the negatives of DHT. What this means is that the product will most likely be suppressive and require a post cycle, but not cycle support. It also won't have androgenic side affects like hair loss, acne, etc. The increase in follistatin caused by YK11 will act as an antagonist to mystatin (it will block myostatin) as well as the anabolic growth properties of YK11.
How it works?
Animal Research:
In direct comparison to to LGD-4033 as the reference for assay upon animal models of anabolism and androgenicity, YK-11 demonstrated higher efficacy withing anabolic parameters and lesser androgenicity at equivalent dosages.
It induces muscle cells to make more follistatin which is a strong myostatin inhibitor. Myostatin (also known as growth differentiation factor 8, is a myokine (protein) produced by muscle cells that acts on muscle cells to inhibit myogenesis. Myogenesis is muscle cell growth and differentiation. Research through the years show that when you block myostatin, it allows for significantly more muscle mass. So in research myostatin inhibitors are researched to find cures for muscle diseases.
We expect YK11 to be more potent than SARM LGD in terms of overall growth and feel. At this time, we expect this to be the strongest SARM on the market at a regular dosing. While suppression can occur, we expect this product to have low androgenic properties and can be used by both men and women. From our experience with SARMs, we find there are less losses of on-cycle results than pro-hormones, although typically not as potent. We do expect this product to have similar results as a moderately dosed Halodrol, without the alpha-male/androgenic feelings while on it.
Dosages and Suggestion
Recommended maximum dose YK11 is require dosages of 2.0-5.0mg b.i.d. in males and 0.5mg-2mg b.i.d. in females to achieve optimal effects in humans for the noted indications.
We are supplying:
Tam*oxif*en citrate/No*lvad*ex
CAS: 54965-24-1
Â
Raws Name(hot sell)
Abbr
Test* Base
TB
Test* EnanÂ
TE
Test* CypÂ
TC
Test* IsoÂ
TI
Test* DecaÂ
TD
Test* UndeÂ
TU
Test* PropÂ
TP
Test* PhenylpÂ
TPP
Test* aceÂ
TA
Sus250 (Test mixed)
s250
4-Chlorotest aceÂ
/
4-ChlorodehydromethyltÂ
/
Â
Â
BoldÂ
B
Bold aceÂ
BA
Bold* Unde*Â Â EQ
BU
Bold CypÂ
BC
Â
Â
NandÂ
N
Na*nd*Â Â De*caÂ
ND
Nand  CyÂ
NC
Nand  Unde Â
NU
Nand*Â Â PhenylpÂ
N*P*P
Â
Â
Oxan /AnavÂ
OA
Oxyme  /AnadrÂ
Oxy
Stano /Winstr
ST
Metand /Danab
DB
Tr*en* ace (Revalor-H)
TBA
Tr*en* EnanÂ
TBE
Methe ace*tateÂ
MA
Methe enan*thate
ME
Dros*tano*l Enan
DE
Drosta*nolo* Prop*ionate(Maste)
DP
                                  and so on …
Â
Â
Â
Peptides Name
Spec
GHR*-6
5mg
GHR*-2
5mgÂ
Ipamor*linÂ
2mg 5mg
M*lanotan I
10mgÂ
M*-II
10mg
CJ*-1295 (DAC)
2mgÂ
CJ*-1295 (without DAC)
2mgÂ
MG* (IG*-1 EC)
2mg
P*-141
10mg
S*rmorelinÂ
2mgÂ
P*G-MGFÂ
2mgÂ
DS*IP
2mg 5mg
sel*ankÂ
2mg
Oxyt*ocin
2mgÂ
Gonado*relinÂ
2mgÂ
Tripto*relinÂ
100ug
GH*RHÂ
2mgÂ
Tesa*morelinÂ
2mg
Fra*g(176-191)
2mg 5mgÂ
Hexareli*n
2mg 5mg 10mg
Thymos*in Beta 4Â (TB4) Model: TB-500
2mg 5mg 10mg
H*H blue/red/green/yellow to*ps Â
 10iu
Hy*getropin/Jin*tropin/Kig*tropin/Rip*tropinÂ
10iuÂ
H*C*G
5000iuÂ
Â
Â
Sarms
Â
MK2866
841205-47-8
SR9009
1379686-30-2
RAD140
1182367-47-0
MK677
15972-10-0
S4
401900-40-1
YK11
431579-34-9
LGD-4033
1165910-22-4
GW-501516
317318-70-0
* Safe and fast delivery
* Special and concealed package
* Competitive and reasonable price
Please feel free to contact us and we will do our best to help you. Thank you.
Â
Hubei Zhaoke Bio-Chemical Co., Ltd.
Â
What is YK11?
(17α,20E)-17,20-[(1-methoxyethylidene)bis-(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester (YK11), which the myogenic differentiation of C2C12 myoblast cells is induced by the novel androgen receptor (AR) partial agonist.Â
YK11 is a selective androgen receptor modulator (SARM), which activates AR without the N/C interaction. In this study, we further investigated the mechanism by which YK11 induces myogenic differentiation of C2C12 cells. The induction of key myogenic regulatory factors (MRFs), such as myogenic differentiation factor (MyoD), myogenic factor 5 (Myf5) and myogenin, was more significant in the presence of YK11 than in the presence of DHT. YK11 treatment of C2C12 cells, but not DHT, induced the expression of follistatin (Fst), and the YK11-mediated myogenic differentiation was reversed by anti-Fst antibody.
Myogenic differentiation is in reference to the products ability to block myostatin. Myostatin inhibition has been a really popular movement since the ban of most prohormones as it looks to be a relatively unexplored area for muscle growth and fat loss. There are currently a lot of claims about mystatin inhibition, but not so much factual data on these products. YK11 will have similar affects to DHT (possibly more potent) without the negatives of DHT. What this means is that the product will most likely be suppressive and require a post cycle, but not cycle support. It also won't have androgenic side affects like hair loss, acne, etc. The increase in follistatin caused by YK11 will act as an antagonist to mystatin (it will block myostatin) as well as the anabolic growth properties of YK11.
How it works?
Animal Research:
In direct comparison to to LGD-4033 as the reference for assay upon animal models of anabolism and androgenicity, YK-11 demonstrated higher efficacy withing anabolic parameters and lesser androgenicity at equivalent dosages.
It induces muscle cells to make more follistatin which is a strong myostatin inhibitor. Myostatin (also known as growth differentiation factor 8, is a myokine (protein) produced by muscle cells that acts on muscle cells to inhibit myogenesis. Myogenesis is muscle cell growth and differentiation. Research through the years show that when you block myostatin, it allows for significantly more muscle mass. So in research myostatin inhibitors are researched to find cures for muscle diseases.
We expect YK11 to be more potent than SARM LGD in terms of overall growth and feel. At this time, we expect this to be the strongest SARM on the market at a regular dosing. While suppression can occur, we expect this product to have low androgenic properties and can be used by both men and women. From our experience with SARMs, we find there are less losses of on-cycle results than pro-hormones, although typically not as potent. We do expect this product to have similar results as a moderately dosed Halodrol, without the alpha-male/androgenic feelings while on it.
Dosages and Suggestion
Recommended maximum dose YK11 is require dosages of 2.0-5.0mg b.i.d. in males and 0.5mg-2mg b.i.d. in females to achieve optimal effects in humans for the noted indications.
We are supplying:
Tam*oxif*en citrate/No*lvad*ex
CAS: 54965-24-1
Â
Raws Name(hot sell)
Abbr
Test* Base
TB
Test* EnanÂ
TE
Test* CypÂ
TC
Test* IsoÂ
TI
Test* DecaÂ
TD
Test* UndeÂ
TU
Test* PropÂ
TP
Test* PhenylpÂ
TPP
Test* aceÂ
TA
Sus250 (Test mixed)
s250
4-Chlorotest aceÂ
/
4-ChlorodehydromethyltÂ
/
Â
Â
BoldÂ
B
Bold aceÂ
BA
Bold* Unde*Â Â EQ
BU
Bold CypÂ
BC
Â
Â
NandÂ
N
Na*nd*Â Â De*caÂ
ND
Nand  CyÂ
NC
Nand  Unde Â
NU
Nand*Â Â PhenylpÂ
N*P*P
Â
Â
Oxan /AnavÂ
OA
Oxyme  /AnadrÂ
Oxy
Stano /Winstr
ST
Metand /Danab
DB
Tr*en* ace (Revalor-H)
TBA
Tr*en* EnanÂ
TBE
Methe ace*tateÂ
MA
Methe enan*thate
ME
Dros*tano*l Enan
DE
Drosta*nolo* Prop*ionate(Maste)
DP
                                  and so on …
Â
Â
Â
Peptides Name
Spec
GHR*-6
5mg
GHR*-2
5mgÂ
Ipamor*linÂ
2mg 5mg
M*lanotan I
10mgÂ
M*-II
10mg
CJ*-1295 (DAC)
2mgÂ
CJ*-1295 (without DAC)
2mgÂ
MG* (IG*-1 EC)
2mg
P*-141
10mg
S*rmorelinÂ
2mgÂ
P*G-MGFÂ
2mgÂ
DS*IP
2mg 5mg
sel*ankÂ
2mg
Oxyt*ocin
2mgÂ
Gonado*relinÂ
2mgÂ
Tripto*relinÂ
100ug
GH*RHÂ
2mgÂ
Tesa*morelinÂ
2mg
Fra*g(176-191)
2mg 5mgÂ
Hexareli*n
2mg 5mg 10mg
Thymos*in Beta 4Â (TB4) Model: TB-500
2mg 5mg 10mg
H*H blue/red/green/yellow to*ps Â
 10iu
Hy*getropin/Jin*tropin/Kig*tropin/Rip*tropinÂ
10iuÂ
H*C*G
5000iuÂ
Â
Â
Sarms
Â
MK2866
841205-47-8
SR9009
1379686-30-2
RAD140
1182367-47-0
MK677
15972-10-0
S4
401900-40-1
YK11
431579-34-9
LGD-4033
1165910-22-4
GW-501516
317318-70-0
* Safe and fast delivery
* Special and concealed package
* Competitive and reasonable price
Please feel free to contact us and we will do our best to help you. Thank you.
Â
Hubei Zhaoke Bio-Chemical Co., Ltd.
Â
((17α , 20E) -17, 20-[ (1-methoxyethylidene) Bis- (oxy) ]-3-Oxo-19-Norpregna-4, 20-Diene-21-Carbo Sarms Yk11
Model NO.: YK11
Classification: Sarms
Assay: 99%
Trademark: zhaoke
Transport Package: Aluminum Foil Bag
Specification: USP
Origin: China
Model NO.: YK11
Classification: Sarms
Assay: 99%
Trademark: zhaoke
Transport Package: Aluminum Foil Bag
Specification: USP
Origin: China
What is YK11?